ClinicalTrialsFinder
RecruitingPhase 3NCT07222852

Cardiovascular Protection After Preeclampsia With Enalapril

Sponsor

Women and Infants Hospital of Rhode Island

Enrollment

60 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

HypertensionPreeclampsiaHypertensive Disorder of PregnancyGestational HypertensionGestational Hypertension After Childbirth

Summary

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Enalapril and Standard treatment for people with gestational hypertension, gestational hypertension after childbirth, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEnalapril

First-line anti-hypertensive treatment with enalapril

OTHERStandard treatment

First-line anti-hypertensive treatment per standard of care

Locations(1)

Women and Infants Hospital

Providence, Rhode Island, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07222852

Related Trials

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

NCT07181109995 locations

Diabetes and Heart Disease Risk in Blacks

NCT000018531 location

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT070644731149 locations

Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy

NCT072182372 locations

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

NCT033742151 location